Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Acute rejection of a transplanted organ by the recipient is mediated by an inflammatory immune response.
Despite current immunosuppressive therapies, organ rejection remains problematic.
In this issue of the Journal of Clinical Investigation, Craig Morrell and colleagues of the University of Rochester discovered that mice lacking the chemokine, platelet factor 4 (PF4), had an enhanced immune response to heart transplant that was associated with an increase in Th17 cells.
The authors found that PF4 was essential for limiting the differentiation of naive T cells into the Th17 subtype.
In a companion Commentary, Ronjon Chakraverty of University College London discusses this exciting new role for platelets in limiting transplant rejection.
TITLE: Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection ACCOMPANYING COMMENTARY
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Transplants / Organ Donations category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Journal of Clinical Investigation. "Murine cardiac graft rejection limited by a platelet-derived factor." Medical News Today. MediLexicon, Intl., 29 Jan. 2014. Web.
23 Apr. 2014. <http://www.medicalnewstoday.com/releases/271797>
Journal of Clinical Investigation. (2014, January 29). "Murine cardiac graft rejection limited by a platelet-derived factor." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/271797.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.